Sedia Biosciences is a leading biotechnology brand committed to advancing global access to care. They offer a wide range of innovative products and services that contribute to the improvement of medical diagnostics, disease surveillance, and public health monitoring. Their product portfolio includes state-of-the-art rapid point-of-care diagnostic assays such as the SEDIA® HIV-1 LAg-Avidity EIA and Asanté® Rapid Recency® Assay.

These assays are designed to estimate the incidence of HIV infection, monitor the evolution of the HIV epidemic, and identify new infection outbreaks and hotspots. Sedia is dedicated to making their tools equally available to all people and populations globally, with the aim of advancing access to medical care and health. The brand also places a strong emphasis on social responsibility and ethical accountability.

They strive to bring high-quality, affordable products to the market and work to minimize their impact on the environment. If you want to learn more about Sedia Biosciences or have any questions, feel free to reach out to them through their website or contact details provided